Resonance Health Limited Share Price
Equities
RHT
AU000000RHT2
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 AUD | 0.00% | +7.59% | +41.67% |
Sales 2022 | 3.85M 2.52M 210M | Sales 2023 | 4.47M 2.93M 244M | Capitalization | 19.37M 12.68M 1.06B |
---|---|---|---|---|---|
Net income 2022 | -1M -655K -54.54M | Net income 2023 | - 0 0 | EV / Sales 2022 | 5.01 x |
Net cash position 2022 | 6.51M 4.26M 355M | Net cash position 2023 | 6.09M 3.99M 332M | EV / Sales 2023 | 2.97 x |
P/E ratio 2022 |
-22.4
x | P/E ratio 2023 |
-24.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.37% |
1 week | +7.59% | ||
Current month | +21.43% | ||
1 month | +11.84% | ||
3 months | +66.67% | ||
6 months | +51.79% | ||
Current year | +41.67% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Harrison
CEO | Chief Executive Officer | - | 01/23/01 |
John Olynyk
CTO | Chief Tech/Sci/R&D Officer | - | 24/21/24 |
Mitchell Wells
BRD | Director/Board Member | 48 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Wells
BRD | Director/Board Member | 48 | 01/17/01 |
Martin Blake
CHM | Chairman | - | 04/07/04 |
Simon Panton
BRD | Director/Board Member | - | 05/09/05 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.085 | 0.00% | 17 574 |
26/24/26 | 0.085 | 0.00% | 14,000 |
24/24/24 | 0.085 | +4.94% | 12,683 |
23/24/23 | 0.081 | +2.53% | 380,000 |
22/24/22 | 0.079 | -2.47% | 328,149 |
Delayed Quote Australian S.E., April 29, 2024 at 05:36 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+41.67% | 24.77M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- RHT Stock